Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 475,923 shares of Common Stock, (2) Series A Preferred Shares convertible into 27,107,210 shares of Common Stock (subject to a 9.99% beneficial ownership limitation), and (3) Warrants to acquire 54,214,420 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is giving effect to the 9.99% beneficial ownership limitation and is calculated based on (a) 16,192,438 shares of Common Stock outstanding as of May 12, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending March 31, 2026, plus (b) the approximate total number of shares of Common Stock that the reporting persons may acquire upon exercise of all Preferred Shares and Warrants (subject to the 9.99% beneficial ownership limitation).


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 475,923 shares of Common Stock, (2) Series A Preferred Shares convertible into 27,107,210 shares of Common Stock (subject to a 9.99% beneficial ownership limitation), and (3) Warrants to acquire 54,214,420 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is giving effect to the 9.99% beneficial ownership limitation and is calculated based on (a) 16,192,438 shares of Common Stock outstanding as of May 12, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending March 31, 2026, plus (b) the approximate total number of shares of Common Stock that the reporting persons may acquire upon exercise of all Preferred Shares and Warrants (subject to the 9.99% beneficial ownership limitation).


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 475,923 shares of Common Stock, (2) Series A Preferred Shares convertible into 27,107,210 shares of Common Stock (subject to a 9.99% beneficial ownership limitation), and (3) Warrants to acquire 54,214,420 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is giving effect to the 9.99% beneficial ownership limitation and is calculated based on (a) 16,192,438 shares of Common Stock outstanding as of May 12, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending March 31, 2026, plus (b) the approximate total number of shares of Common Stock that the reporting persons may acquire upon exercise of all Preferred Shares and Warrants (subject to the 9.99% beneficial ownership limitation).


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 475,923 shares of Common Stock, (2) Series A Preferred Shares convertible into 27,107,210 shares of Common Stock (subject to a 9.99% beneficial ownership limitation), and (3) Warrants to acquire 54,214,420 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. The percentage reported herein is giving effect to the 9.99% beneficial ownership limitation and is calculated based on (a) 16,192,438 shares of Common Stock outstanding as of May 12, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ending March 31, 2026, plus (b) the approximate total number of shares of Common Stock that the reporting persons may acquire upon exercise of all Preferred Shares and Warrants (subject to the 9.99% beneficial ownership limitation).


SCHEDULE 13G



 
Stonepine Capital Management, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:06/22/2026
 
Stonepine Capital, L.P.
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:06/22/2026
 
Stonepine GP, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:06/22/2026
 
Jon M. Plexico
 
Signature:/s/ Jon M. Plexico
Name/Title:Reporting Person
Date:06/22/2026
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G.

EXHIBIT 99

 

AGREEMENT REGARDING JOINT FILING

OF STATEMENT ON SCHEDULE 13D OR 13G

 

The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigned hereby constitute and appoint Stonepine Capital Management, LLC, a Delaware limited liability company, as their true and lawful agent and attorney-in-fact, with full power and authority for and on behalf of the undersigned to prepare or cause to be prepared, sign, file with the SEC and furnish to any other person all certificates, instruments, agreements and documents necessary to comply with section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as amended, in connection with said purchases, and to do and perform every act necessary and proper to be done incident to the exercise of the foregoing power, as fully as the undersigned might or could do if personally present.

 

Dated: October 10, 2024

 

 

STONEPINE CAPITAL MANAGEMENT, LLC


By: /s/ Jon M. Plexico
Jon M. Plexico
Managing Member

 

 

STONEPINE CAPITAL, L.P.

By: Stonepine GP, LLC,
General Partner

By: /s/ Jon M. Plexico
Jon M. Plexico
Managing Member

 

 

STONEPINE GP, LLC


By: /s/ Jon M. Plexico
Jon M. Plexico
Managing Member

 

 

 

/s/ Jon M. Plexico

Jon M. Plexico